Searched for
ASCENT PHARMA
Strides Pharma sells majority stake in arm Pivot Path for Rs 100 croreStrides Pharma Science has divested a majority stake in its subsidiary, Pivot Path, for Rs 100 crore to a consortium led by Ascent Capital ...- Maiva Pharma raises Rs 1000 crore from Morgan Stanley Private Equity, InvAscentMorgan Stanley PE Asia and India Life Sciences Fund are investing almost equally, total stake with both funds combined will be over 60% pos...
- API maker Fleming Laboratories raises Rs 110 cr from PE fund InvAscentFleming is a backward integrated API manufacturer with global leadership in select muscle relaxant, anti-arthritis, and antihistamine APIs ...
- PE fund InvAscent puts $10 million in health-tech SaaS firm ABI Health TechnologiesThe company’s product, ClaimBook, helps a hospital to automate its entire health insurance claims management process, improving revenue cyc...
- Women’s contraceptive products maker Pregna International raises Rs 130 crore from India Life Sciences FundFounded in the 1990s by Late Shyamsunder Taparia, Jaiprakash Taparia and family, Pregna is a contraception devices maker in the global IUD ...
- NSE-BSE bulk deals: Ascent India Fund cuts stake in Solara Active PharmaAscent India Fund III sold 3,41,848 shares of Solara Active Pharma Sciences at Rs 1,212.64 per share. The fund held 2.11 per cent stake in ...
- Everstone to invest $50 million in KKR-backed Slayback PharmaEverstone joins existing institutional investor KKR, who first invested in Slayback with a $60 million commitment in December 2016.
- Founders seeking exit value Sequent Scientific at Rs 2,500 croreSequent’s market cap as on Tuesday was Rs 1,670 crore. But the founders are seeking a control premium of 49.7% or 18-20x forward Ebitda mul...
- Temasek lining up $100 million for Ascent Health and WellnessEquity financing round may value Mumbai-based co at $650-700 million.
- PharmEasy is closing in on $120 million in equity roundThe transaction, which is expected to close by the end of the month, will value the five-yearold company at $500-600 million, according to ...
- PharmEasy and Ascent Health in merger talksBoards of two firms believed to have given in-principle nod for an all-stock transaction.
- InvAscent-led India Life Sciences Fund raises $250 millionInvestors of the fund include blue chip fund-of-fund vehicles, pension funds and university endowments and family offices from the US and E...
- Ascent Health racks up multiple acquisitions post Rs 400 crore Everstone fundingAscent Health is eyeing up to 10 acquisitions by the end of the current fiscal, according to the company’s CEO Siddharth Shah.
- Evolvence India Fund to exit Neuland Labs; puts entire stake of 33 per cent on saleVishy Chebrol, one of the founders and managing directors of InvAscent, confirmed the fund is looking at exiting its investment in the comp...
- Mainstay gone, strides in for a rough rideThe company had earlier acquired assets, improved efficiencies and subsequently sold them at attractive valuations.
- Strides Arcolab redeems $80 million FCCBsStrides Arcolab announced that it has redeemed the outstanding $80 million (Rs 456.48 crore) foreign currency convertible bonds (FCCBs).
- Strides Arcolab January-March net profit zooms to Rs 642 croreThe Bangalore-headquartered firm had sold its entire stake in Australian subsidiary Ascent Pharmahealth to Watson Pharmaceuticals.
- Strides Arcolab sold 94% stake in its subsidiary Ascent Pharma health to Watson PharmaceuticalsArcolab sold 94% stake in its subsidiary Ascent Pharmahealth to Watson Pharmaceuticals for an undisclosed amount.
- Strides to up stake in Australian pharma to 94%Strides Arcolab will be consolidating its stake in Australian firm Ascent Pharmahealth. Currently, it holds 60.3% in the firm and plans to ...
- Strides proposes to acquire minority stake in Ascent PharmaDrug maker Strides Arcolab on Tuesday said it is in talks with Ascent Pharmahealth, listed on the Australian Stock Exchange, for acquiring ...
Load More
